Filing Details
- Accession Number:
- 0001181431-10-009608
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-17 12:00:00
- Reporting Period:
- 2010-02-16
- Filing Date:
- 2010-02-17
- Accepted Time:
- 2010-02-17 15:33:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 722104 | Savient Pharmaceuticals Inc | SVNT | Medicinal Chemicals & Botanical Products (2833) | 133033811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1250318 | K Philip Yachmetz | Savient Pharmaceuticals, Inc. One Tower Center, 14Th Floor East Brunswick NJ 08816 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value Per Share | Disposition | 2010-02-16 | 2,471 | $13.80 | 170,434 | No | 4 | S | Direct | |
| Common Stock, $.01 Par Value Per Share | Disposition | 2010-02-16 | 3,307 | $13.79 | 167,127 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 15, 2007.
- These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 13, 2009.
Billionaire Hedge Funds
